In the immune compartment, eATP engages the P2X7 expressed by dendritic cells activating the NLRP3 inflammasome and promoting the release of IL-1β that, together with antigen presentation, triggers an anti-tumour immune response (Ghiringhelli et al., 2009) (Figure 2A). The gene discussed is P2RX7; the disease is neoplasm.